Literature DB >> 6596301

The pharmacokinetics and tissue penetration of ofloxacin.

M R Lockley, R Wise, J Dent.   

Abstract

The pharmacokinetics of the 4-quinolone agent, ofloxacin, were studied in six healthy volunteers, following a 600 mg oral dose. The levels of the compound were measured by a microbiological assay in serum, blister fluid and urine. The compound was rapidly absorbed, the mean maximum concentration of ofloxacin being 10.7 mg/l at 1.2 h. The mean serum elimination half-life was 7 h and 80.3% of the administered compound was recovered in the urine by 48 h. Ofloxacin penetrated the blister fluid well, the mean peak level being 5.2 mg/l at 5.3 h.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6596301     DOI: 10.1093/jac/14.6.647

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  54 in total

1.  Sequential therapy with ofloxacin in complicated urinary tract infections: a randomized comparative study with ciprofloxacin.

Authors:  H J Peters
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Mycobacteria and the new quinolones.

Authors:  D C Leysen; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

4.  Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.

Authors:  R Wise; B Kirkpatrick; J Ashby; D J Griggs
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

5.  Effect of renal impairment on distribution of ofloxacin.

Authors:  A Sanchez Navarro; J Martinez Lanao; M M Sanchez Recio; A Domínguez-Gil Hurlé; J M Tabernero Romo; J C Gomez Sanchez; M M Terreiro Delgado
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

6.  Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection.

Authors:  J R Black; J M Long; B E Zwickl; B S Ray; M S Verdon; S Wetherby; E W Hook; H H Handsfield
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

Review 7.  Quinolones in Salmonella typhi infection.

Authors:  H L DuPont
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.

Authors:  S L Gregoire; T H Grasela; J P Freer; K J Tack; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

9.  Ofloxacin pharmacokinetics in renal failure.

Authors:  J P Fillastre; A Leroy; G Humbert
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.

Authors:  H Tomioka; H Saito; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.